Jordan Kanfer

Jordan Kanfer brings over 25 years of healthcare financial experience to Athenex. He is currently a Managing Director at Opti Capital Management, a hedge fund focused on convertible bond arbitrage. He was most recently a Portfolio Manager/Healthcare Sector head at Arrowgrass Capital Partners, a $6 billion hedge fund headquartered in London.

Previously, Jordan worked at various hedge funds including TPG-Axon and Jana Partners where he spent the bulk of his investing career. Prior to joining the buyside, he worked at Goldman, Sachs & Co. where he was a sell side equity research analyst covering the Healthcare Facilities and Healthcare Services sectors. Before joining Goldman Sachs & Co., he worked in the healthcare industry as a consultant for Kurt Salmon Associates and had various operational roles at Montefiore Medical Center.

Jordan is a member of the American College of Healthcare Executives, a special advisor to Microbion, an early stage anti-effectives company, and he is on the board of advisors for dB Diagnostics, an emerging healthcare technology company focused on improving the diagnosis of hearing loss. Jordan holds a Master of Public Health degree from the University of Massachusetts and a Bachelor of Arts from Yeshiva University.